Concepedia

Publication | Open Access

A long-term open-label safety study of galcanezumab in Japanese patients with migraine

DOIFull Paper Access

29

Citations

26

References

2021

Year

Koichi Hirata, Takao Takeshima, Fumihiko Sakai, Yoshihisa Tatsuoka, Norihiro Suzuki, Hisaka Igarashi, Tomomi Nakamura, Akichika Ozeki, Hiroyoshi Yamazaki, Vladimir Skljarevski
Expert Opinion on Drug Safety

Abstract

https://clinicaltrials.gov, identifier: NCT02959190.

References

YearCitations

Page 1